statistical software package statview version 5.0 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
statistical software package statview version 5.0
Statistical Software Package Statview Version 5.0, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+software+package+statview+version+5%2E0/statview+5+0/pm32621280-41-6-12
Average 90 stars, based on 1 article reviews
Statistical Software Package Statview Version 5.0, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+software+package+statview+version+5%2E0/statview+5+0/pm32621280-41-6-12
Average 90 stars, based on 1 article reviews
statistical software package statview version 5.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group. Article Snippet: .. Statistical calculations were performed with a Article Title: Prognostic factors of stage I thymic epithelial tumors. Article Snippet: Objective According to the tumor-node-metastasis classification for thymic malignancies, the proportion of patients diagnosed with stage I is expected to increase significantly.. However, whether those patients have homogenous clinicopathological features and survival has not been fully evaluated.. Methods We reviewed 153 consecutive patients with stage I thymic epithelial tumors (133 thymomas, 15 thymic carcinomas, and 5 neuroendocrine tumors) who underwent complete resection at our institution between 2001 and 2016 and evaluated the prognostic significance of their clinicopathological factors. Article Title: Prognostic impact of pleural lavage cytology in patients with primary lung cancer. Article Snippet: Objectives: Positive pleural lavage cytology (PLC) has been reported to have a negative prognostic impact in patients with surgically resected non-small cell lung cancer (NSCLC).. However, positive PLC does not upgrade the stage according to the 7th edition of TNM classification for lung cancer.. The objectives of this study were to evaluate the prognostic impact of positive PLC in patients with NSCLC and to clarify its contribution to TNM classification. Article Title: Prognostic impact of tumour size in completely resected thymic epithelial tumours. Article Snippet: .. Statistical calculations were performed with a Article Title: Discrimination Between Patients With Alzheimer Disease and Healthy Subjects Using Layer Analysis of Cerebral Blood Flow and Xenon Solubility Coefficient in Xenon-Enhanced Computed Tomography Article Snippet: Objective: The aim of this study was to develop a method for discriminating between patients with Alzheimer disease (AD) and healthy subjects using layer analysis of cerebral blood flow (CBF) and xenon solubility coefficient (λ) in xenon-enhanced computed tomography (CT).. Methods: Xenon-enhanced CTwas performed on 27 patients with AD (81.7 [3.3]years old) and 15 healthy volunteers (78.6 [4.0]years old) using awide volume CT. For each subject, we created the first(surface) to sixthlayer images of CBF and λ for the 6 viewing directions (layer thickness, 5 mm).. For the discriminant views, receiver operating characteristic curves for the ratio of CBF to λ were created to identify patients with AD. Article Title: Discrimination between patients with mild Alzheimer's disease and healthy subjects based on cerebral blood flow images of the lateral views in xenon-enhanced computed tomography. Article Snippet: Anzai Medical Co., Ltd., Tokyo and Department of Neuropsychiatry, Sawa Hospital, Osaka, Japan Correspondence: Dr Shigeru Sase PhD, Anzai Medical Co., Ltd., 3-9-15 Nishi-Shinagawa Shinagawa-ku, Tokyo 141-0033, Japan.. Email: sase@anzai-med.co.jp Disclosure: The authors have no conflicts of interest or financial ties to disclose.. Received 9 March 2017; revision received 12 April 2017; accepted 27 April 2017. Article Title: Prevalence of oral hygiene tools amongst hospitalised elders: A cross-sectional survey. Article Snippet: 1Division of Gerodontology and Removable Prosthodontics, University Clinics of Dental Medicine, University of Geneva, Geneva, Switzerland 2Division of Gerodontology, University of Bern, Bern, Switzerland 3Service of Geriatrics, Department of Internal Medicine, Rehabilitation and Geriatrics, Geneva University Hospitals, Thônex, Switzerland 4Department of Internal Medicine and Rehabilitation (Trois‐Chêne), Geneva University Hospitals, Geneva, Switzerland Article Title: Conditional Survival After Surgical Intervention in Patients With Non-Small Cell Lung Cancer. Article Snippet: .. Statistical calculations were performed using a |